Global Poultry Live Attenuated Vaccine Market Growth 2026-2032
The global Poultry Live Attenuated Vaccine market size is predicted to grow from US$ 2205 million in 2025 to US$ 2741 million in 2032; it is expected to grow at a CAGR of 3.2% from 2026 to 2032.
Poultry live attenuated vaccines are a type of vaccine used in the poultry industry to protect birds from various infectious diseases. Live attenuated vaccines contain weakened or modified forms of the pathogen that causes the disease, allowing the bird?s immune system to develop a protective response without causing severe illness.
United States market for Poultry Live Attenuated Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Poultry Live Attenuated Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Poultry Live Attenuated Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Poultry Live Attenuated Vaccine players cover MERCK, Boehringer Ingelheim, CEVA, ZOETIS, Vaxxinova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Poultry Live Attenuated Vaccine Industry Forecast? looks at past sales and reviews total world Poultry Live Attenuated Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Poultry Live Attenuated Vaccine sales for 2026 through 2032. With Poultry Live Attenuated Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poultry Live Attenuated Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Poultry Live Attenuated Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poultry Live Attenuated Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Poultry Live Attenuated Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poultry Live Attenuated Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poultry Live Attenuated Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Poultry Live Attenuated Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Poultry live attenuated vaccines are a type of vaccine used in the poultry industry to protect birds from various infectious diseases. Live attenuated vaccines contain weakened or modified forms of the pathogen that causes the disease, allowing the bird?s immune system to develop a protective response without causing severe illness.
United States market for Poultry Live Attenuated Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Poultry Live Attenuated Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Poultry Live Attenuated Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Poultry Live Attenuated Vaccine players cover MERCK, Boehringer Ingelheim, CEVA, ZOETIS, Vaxxinova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Poultry Live Attenuated Vaccine Industry Forecast? looks at past sales and reviews total world Poultry Live Attenuated Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Poultry Live Attenuated Vaccine sales for 2026 through 2032. With Poultry Live Attenuated Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poultry Live Attenuated Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Poultry Live Attenuated Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poultry Live Attenuated Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Poultry Live Attenuated Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poultry Live Attenuated Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poultry Live Attenuated Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Poultry Live Attenuated Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- NDV
- Marek ' s Disease
- IBD
- Infectious Bronchitis
- Influenza
- Other
- Chicken
- Other Poultry
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- MERCK
- Boehringer Ingelheim
- CEVA
- ZOETIS
- Vaxxinova
- ELANCO
- QYH BIOTECH
- PULIKE
- PHIBRO ANIMAL HEALTH CORPORATION
- HARBIN PHARMACEUTICAL GROUP
- MEVAC
- VENKY?S
- Dechra
- What is the 10-year outlook for the global Poultry Live Attenuated Vaccine market?
- What factors are driving Poultry Live Attenuated Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Poultry Live Attenuated Vaccine market opportunities vary by end market size?
- How does Poultry Live Attenuated Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Poultry Live Attenuated Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Poultry Live Attenuated Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Poultry Live Attenuated Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Poultry Live Attenuated Vaccine Segment by Type
2.2.1 NDV
2.2.2 Marek ' s Disease
2.2.3 IBD
2.2.4 Infectious Bronchitis
2.2.5 Influenza
2.2.6 Other
2.2.7 Poultry Live Attenuated Vaccine Sales by Type
2.2.7.1 Global Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
2.2.7.2 Global Poultry Live Attenuated Vaccine Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Poultry Live Attenuated Vaccine Sale Price by Type (2021-2026)
2.3 Poultry Live Attenuated Vaccine Segment by Application
2.3.1 Chicken
2.3.2 Other Poultry
2.3.3 Poultry Live Attenuated Vaccine Sales by Application
2.3.3.1 Global Poultry Live Attenuated Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Poultry Live Attenuated Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Poultry Live Attenuated Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Poultry Live Attenuated Vaccine Breakdown Data by Company
3.1.1 Global Poultry Live Attenuated Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Poultry Live Attenuated Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Poultry Live Attenuated Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Poultry Live Attenuated Vaccine Revenue by Company (2021-2026)
3.2.2 Global Poultry Live Attenuated Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Poultry Live Attenuated Vaccine Sale Price by Company
3.4 Key Manufacturers Poultry Live Attenuated Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Poultry Live Attenuated Vaccine Product Location Distribution
3.4.2 Players Poultry Live Attenuated Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POULTRY LIVE ATTENUATED VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Poultry Live Attenuated Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Poultry Live Attenuated Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Poultry Live Attenuated Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Poultry Live Attenuated Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Poultry Live Attenuated Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Poultry Live Attenuated Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Poultry Live Attenuated Vaccine Sales Growth
4.4 APAC Poultry Live Attenuated Vaccine Sales Growth
4.5 Europe Poultry Live Attenuated Vaccine Sales Growth
4.6 Middle East & Africa Poultry Live Attenuated Vaccine Sales Growth
5 AMERICAS
5.1 Americas Poultry Live Attenuated Vaccine Sales by Country
5.1.1 Americas Poultry Live Attenuated Vaccine Sales by Country (2021-2026)
5.1.2 Americas Poultry Live Attenuated Vaccine Revenue by Country (2021-2026)
5.2 Americas Poultry Live Attenuated Vaccine Sales by Type (2021-2026)
5.3 Americas Poultry Live Attenuated Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Poultry Live Attenuated Vaccine Sales by Region
6.1.1 APAC Poultry Live Attenuated Vaccine Sales by Region (2021-2026)
6.1.2 APAC Poultry Live Attenuated Vaccine Revenue by Region (2021-2026)
6.2 APAC Poultry Live Attenuated Vaccine Sales by Type (2021-2026)
6.3 APAC Poultry Live Attenuated Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Poultry Live Attenuated Vaccine by Country
7.1.1 Europe Poultry Live Attenuated Vaccine Sales by Country (2021-2026)
7.1.2 Europe Poultry Live Attenuated Vaccine Revenue by Country (2021-2026)
7.2 Europe Poultry Live Attenuated Vaccine Sales by Type (2021-2026)
7.3 Europe Poultry Live Attenuated Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Poultry Live Attenuated Vaccine by Country
8.1.1 Middle East & Africa Poultry Live Attenuated Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Poultry Live Attenuated Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Poultry Live Attenuated Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Poultry Live Attenuated Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Poultry Live Attenuated Vaccine
10.3 Manufacturing Process Analysis of Poultry Live Attenuated Vaccine
10.4 Industry Chain Structure of Poultry Live Attenuated Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Poultry Live Attenuated Vaccine Distributors
11.3 Poultry Live Attenuated Vaccine Customer
12 WORLD FORECAST REVIEW FOR POULTRY LIVE ATTENUATED VACCINE BY GEOGRAPHIC REGION
12.1 Global Poultry Live Attenuated Vaccine Market Size Forecast by Region
12.1.1 Global Poultry Live Attenuated Vaccine Forecast by Region (2027-2032)
12.1.2 Global Poultry Live Attenuated Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Poultry Live Attenuated Vaccine Forecast by Type (2027-2032)
12.7 Global Poultry Live Attenuated Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 MERCK
13.1.1 MERCK Company Information
13.1.2 MERCK Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.1.3 MERCK Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 MERCK Main Business Overview
13.1.5 MERCK Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 CEVA
13.3.1 CEVA Company Information
13.3.2 CEVA Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.3.3 CEVA Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CEVA Main Business Overview
13.3.5 CEVA Latest Developments
13.4 ZOETIS
13.4.1 ZOETIS Company Information
13.4.2 ZOETIS Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.4.3 ZOETIS Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 ZOETIS Main Business Overview
13.4.5 ZOETIS Latest Developments
13.5 Vaxxinova
13.5.1 Vaxxinova Company Information
13.5.2 Vaxxinova Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.5.3 Vaxxinova Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Vaxxinova Main Business Overview
13.5.5 Vaxxinova Latest Developments
13.6 ELANCO
13.6.1 ELANCO Company Information
13.6.2 ELANCO Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.6.3 ELANCO Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 ELANCO Main Business Overview
13.6.5 ELANCO Latest Developments
13.7 QYH BIOTECH
13.7.1 QYH BIOTECH Company Information
13.7.2 QYH BIOTECH Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.7.3 QYH BIOTECH Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 QYH BIOTECH Main Business Overview
13.7.5 QYH BIOTECH Latest Developments
13.8 PULIKE
13.8.1 PULIKE Company Information
13.8.2 PULIKE Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.8.3 PULIKE Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 PULIKE Main Business Overview
13.8.5 PULIKE Latest Developments
13.9 PHIBRO ANIMAL HEALTH CORPORATION
13.9.1 PHIBRO ANIMAL HEALTH CORPORATION Company Information
13.9.2 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.9.3 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 PHIBRO ANIMAL HEALTH CORPORATION Main Business Overview
13.9.5 PHIBRO ANIMAL HEALTH CORPORATION Latest Developments
13.10 HARBIN PHARMACEUTICAL GROUP
13.10.1 HARBIN PHARMACEUTICAL GROUP Company Information
13.10.2 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.10.3 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 HARBIN PHARMACEUTICAL GROUP Main Business Overview
13.10.5 HARBIN PHARMACEUTICAL GROUP Latest Developments
13.11 MEVAC
13.11.1 MEVAC Company Information
13.11.2 MEVAC Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.11.3 MEVAC Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MEVAC Main Business Overview
13.11.5 MEVAC Latest Developments
13.12 VENKY?S
13.12.1 VENKY?S Company Information
13.12.2 VENKY?S Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.12.3 VENKY?S Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 VENKY?S Main Business Overview
13.12.5 VENKY?S Latest Developments
13.13 Dechra
13.13.1 Dechra Company Information
13.13.2 Dechra Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.13.3 Dechra Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Dechra Main Business Overview
13.13.5 Dechra Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Poultry Live Attenuated Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Poultry Live Attenuated Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Poultry Live Attenuated Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Poultry Live Attenuated Vaccine Segment by Type
2.2.1 NDV
2.2.2 Marek ' s Disease
2.2.3 IBD
2.2.4 Infectious Bronchitis
2.2.5 Influenza
2.2.6 Other
2.2.7 Poultry Live Attenuated Vaccine Sales by Type
2.2.7.1 Global Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
2.2.7.2 Global Poultry Live Attenuated Vaccine Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Poultry Live Attenuated Vaccine Sale Price by Type (2021-2026)
2.3 Poultry Live Attenuated Vaccine Segment by Application
2.3.1 Chicken
2.3.2 Other Poultry
2.3.3 Poultry Live Attenuated Vaccine Sales by Application
2.3.3.1 Global Poultry Live Attenuated Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Poultry Live Attenuated Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Poultry Live Attenuated Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Poultry Live Attenuated Vaccine Breakdown Data by Company
3.1.1 Global Poultry Live Attenuated Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Poultry Live Attenuated Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Poultry Live Attenuated Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Poultry Live Attenuated Vaccine Revenue by Company (2021-2026)
3.2.2 Global Poultry Live Attenuated Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Poultry Live Attenuated Vaccine Sale Price by Company
3.4 Key Manufacturers Poultry Live Attenuated Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Poultry Live Attenuated Vaccine Product Location Distribution
3.4.2 Players Poultry Live Attenuated Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POULTRY LIVE ATTENUATED VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Poultry Live Attenuated Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Poultry Live Attenuated Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Poultry Live Attenuated Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Poultry Live Attenuated Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Poultry Live Attenuated Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Poultry Live Attenuated Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Poultry Live Attenuated Vaccine Sales Growth
4.4 APAC Poultry Live Attenuated Vaccine Sales Growth
4.5 Europe Poultry Live Attenuated Vaccine Sales Growth
4.6 Middle East & Africa Poultry Live Attenuated Vaccine Sales Growth
5 AMERICAS
5.1 Americas Poultry Live Attenuated Vaccine Sales by Country
5.1.1 Americas Poultry Live Attenuated Vaccine Sales by Country (2021-2026)
5.1.2 Americas Poultry Live Attenuated Vaccine Revenue by Country (2021-2026)
5.2 Americas Poultry Live Attenuated Vaccine Sales by Type (2021-2026)
5.3 Americas Poultry Live Attenuated Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Poultry Live Attenuated Vaccine Sales by Region
6.1.1 APAC Poultry Live Attenuated Vaccine Sales by Region (2021-2026)
6.1.2 APAC Poultry Live Attenuated Vaccine Revenue by Region (2021-2026)
6.2 APAC Poultry Live Attenuated Vaccine Sales by Type (2021-2026)
6.3 APAC Poultry Live Attenuated Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Poultry Live Attenuated Vaccine by Country
7.1.1 Europe Poultry Live Attenuated Vaccine Sales by Country (2021-2026)
7.1.2 Europe Poultry Live Attenuated Vaccine Revenue by Country (2021-2026)
7.2 Europe Poultry Live Attenuated Vaccine Sales by Type (2021-2026)
7.3 Europe Poultry Live Attenuated Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Poultry Live Attenuated Vaccine by Country
8.1.1 Middle East & Africa Poultry Live Attenuated Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Poultry Live Attenuated Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Poultry Live Attenuated Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Poultry Live Attenuated Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Poultry Live Attenuated Vaccine
10.3 Manufacturing Process Analysis of Poultry Live Attenuated Vaccine
10.4 Industry Chain Structure of Poultry Live Attenuated Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Poultry Live Attenuated Vaccine Distributors
11.3 Poultry Live Attenuated Vaccine Customer
12 WORLD FORECAST REVIEW FOR POULTRY LIVE ATTENUATED VACCINE BY GEOGRAPHIC REGION
12.1 Global Poultry Live Attenuated Vaccine Market Size Forecast by Region
12.1.1 Global Poultry Live Attenuated Vaccine Forecast by Region (2027-2032)
12.1.2 Global Poultry Live Attenuated Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Poultry Live Attenuated Vaccine Forecast by Type (2027-2032)
12.7 Global Poultry Live Attenuated Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 MERCK
13.1.1 MERCK Company Information
13.1.2 MERCK Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.1.3 MERCK Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 MERCK Main Business Overview
13.1.5 MERCK Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 CEVA
13.3.1 CEVA Company Information
13.3.2 CEVA Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.3.3 CEVA Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CEVA Main Business Overview
13.3.5 CEVA Latest Developments
13.4 ZOETIS
13.4.1 ZOETIS Company Information
13.4.2 ZOETIS Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.4.3 ZOETIS Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 ZOETIS Main Business Overview
13.4.5 ZOETIS Latest Developments
13.5 Vaxxinova
13.5.1 Vaxxinova Company Information
13.5.2 Vaxxinova Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.5.3 Vaxxinova Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Vaxxinova Main Business Overview
13.5.5 Vaxxinova Latest Developments
13.6 ELANCO
13.6.1 ELANCO Company Information
13.6.2 ELANCO Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.6.3 ELANCO Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 ELANCO Main Business Overview
13.6.5 ELANCO Latest Developments
13.7 QYH BIOTECH
13.7.1 QYH BIOTECH Company Information
13.7.2 QYH BIOTECH Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.7.3 QYH BIOTECH Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 QYH BIOTECH Main Business Overview
13.7.5 QYH BIOTECH Latest Developments
13.8 PULIKE
13.8.1 PULIKE Company Information
13.8.2 PULIKE Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.8.3 PULIKE Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 PULIKE Main Business Overview
13.8.5 PULIKE Latest Developments
13.9 PHIBRO ANIMAL HEALTH CORPORATION
13.9.1 PHIBRO ANIMAL HEALTH CORPORATION Company Information
13.9.2 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.9.3 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 PHIBRO ANIMAL HEALTH CORPORATION Main Business Overview
13.9.5 PHIBRO ANIMAL HEALTH CORPORATION Latest Developments
13.10 HARBIN PHARMACEUTICAL GROUP
13.10.1 HARBIN PHARMACEUTICAL GROUP Company Information
13.10.2 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.10.3 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 HARBIN PHARMACEUTICAL GROUP Main Business Overview
13.10.5 HARBIN PHARMACEUTICAL GROUP Latest Developments
13.11 MEVAC
13.11.1 MEVAC Company Information
13.11.2 MEVAC Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.11.3 MEVAC Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MEVAC Main Business Overview
13.11.5 MEVAC Latest Developments
13.12 VENKY?S
13.12.1 VENKY?S Company Information
13.12.2 VENKY?S Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.12.3 VENKY?S Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 VENKY?S Main Business Overview
13.12.5 VENKY?S Latest Developments
13.13 Dechra
13.13.1 Dechra Company Information
13.13.2 Dechra Poultry Live Attenuated Vaccine Product Portfolios and Specifications
13.13.3 Dechra Poultry Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Dechra Main Business Overview
13.13.5 Dechra Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Poultry Live Attenuated Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Poultry Live Attenuated Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of NDV
Table 4. Major Players of Marek ' s Disease
Table 5. Major Players of IBD
Table 6. Major Players of Infectious Bronchitis
Table 7. Major Players of Influenza
Table 8. Major Players of Other
Table 9. Global Poultry Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units)
Table 10. Global Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
Table 11. Global Poultry Live Attenuated Vaccine Revenue by Type (2021-2026) & ($ million)
Table 12. Global Poultry Live Attenuated Vaccine Revenue Market Share by Type (2021-2026)
Table 13. Global Poultry Live Attenuated Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Poultry Live Attenuated Vaccine Sale by Application (2021-2026) & (K Units)
Table 15. Global Poultry Live Attenuated Vaccine Sale Market Share by Application (2021-2026)
Table 16. Global Poultry Live Attenuated Vaccine Revenue by Application (2021-2026) & ($ million)
Table 17. Global Poultry Live Attenuated Vaccine Revenue Market Share by Application (2021-2026)
Table 18. Global Poultry Live Attenuated Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Poultry Live Attenuated Vaccine Sales by Company (2021-2026) & (K Units)
Table 20. Global Poultry Live Attenuated Vaccine Sales Market Share by Company (2021-2026)
Table 21. Global Poultry Live Attenuated Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Poultry Live Attenuated Vaccine Revenue Market Share by Company (2021-2026)
Table 23. Global Poultry Live Attenuated Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Poultry Live Attenuated Vaccine Producing Area Distribution and Sales Area
Table 25. Players Poultry Live Attenuated Vaccine Products Offered
Table 26. Poultry Live Attenuated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Poultry Live Attenuated Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Poultry Live Attenuated Vaccine Sales Market Share Geographic Region (2021-2026)
Table 31. Global Poultry Live Attenuated Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Poultry Live Attenuated Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Poultry Live Attenuated Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Poultry Live Attenuated Vaccine Sales Market Share by Country/Region (2021-2026)
Table 35. Global Poultry Live Attenuated Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Poultry Live Attenuated Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Poultry Live Attenuated Vaccine Sales by Country (2021-2026) & (K Units)
Table 38. Americas Poultry Live Attenuated Vaccine Sales Market Share by Country (2021-2026)
Table 39. Americas Poultry Live Attenuated Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Poultry Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units)
Table 41. Americas Poultry Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units)
Table 42. APAC Poultry Live Attenuated Vaccine Sales by Region (2021-2026) & (K Units)
Table 43. APAC Poultry Live Attenuated Vaccine Sales Market Share by Region (2021-2026)
Table 44. APAC Poultry Live Attenuated Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Poultry Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. APAC Poultry Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Europe Poultry Live Attenuated Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Europe Poultry Live Attenuated Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Poultry Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Europe Poultry Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Poultry Live Attenuated Vaccine Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Poultry Live Attenuated Vaccine Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Poultry Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Poultry Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Poultry Live Attenuated Vaccine
Table 56. Key Market Challenges & Risks of Poultry Live Attenuated Vaccine
Table 57. Key Industry Trends of Poultry Live Attenuated Vaccine
Table 58. Poultry Live Attenuated Vaccine Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Poultry Live Attenuated Vaccine Distributors List
Table 61. Poultry Live Attenuated Vaccine Customer List
Table 62. Global Poultry Live Attenuated Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Poultry Live Attenuated Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Poultry Live Attenuated Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Poultry Live Attenuated Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Poultry Live Attenuated Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Poultry Live Attenuated Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Poultry Live Attenuated Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Poultry Live Attenuated Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Poultry Live Attenuated Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Poultry Live Attenuated Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Poultry Live Attenuated Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Poultry Live Attenuated Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Poultry Live Attenuated Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Poultry Live Attenuated Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. MERCK Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 77. MERCK Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 78. MERCK Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. MERCK Main Business
Table 80. MERCK Latest Developments
Table 81. Boehringer Ingelheim Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 82. Boehringer Ingelheim Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 83. Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Boehringer Ingelheim Main Business
Table 85. Boehringer Ingelheim Latest Developments
Table 86. CEVA Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. CEVA Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 88. CEVA Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. CEVA Main Business
Table 90. CEVA Latest Developments
Table 91. ZOETIS Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. ZOETIS Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 93. ZOETIS Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. ZOETIS Main Business
Table 95. ZOETIS Latest Developments
Table 96. Vaxxinova Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. Vaxxinova Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 98. Vaxxinova Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Vaxxinova Main Business
Table 100. Vaxxinova Latest Developments
Table 101. ELANCO Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. ELANCO Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 103. ELANCO Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. ELANCO Main Business
Table 105. ELANCO Latest Developments
Table 106. QYH BIOTECH Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. QYH BIOTECH Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 108. QYH BIOTECH Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. QYH BIOTECH Main Business
Table 110. QYH BIOTECH Latest Developments
Table 111. PULIKE Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. PULIKE Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 113. PULIKE Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. PULIKE Main Business
Table 115. PULIKE Latest Developments
Table 116. PHIBRO ANIMAL HEALTH CORPORATION Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 117. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 118. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. PHIBRO ANIMAL HEALTH CORPORATION Main Business
Table 120. PHIBRO ANIMAL HEALTH CORPORATION Latest Developments
Table 121. HARBIN PHARMACEUTICAL GROUP Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 123. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. HARBIN PHARMACEUTICAL GROUP Main Business
Table 125. HARBIN PHARMACEUTICAL GROUP Latest Developments
Table 126. MEVAC Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 127. MEVAC Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 128. MEVAC Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. MEVAC Main Business
Table 130. MEVAC Latest Developments
Table 131. VENKY?S Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 132. VENKY?S Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 133. VENKY?S Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. VENKY?S Main Business
Table 135. VENKY?S Latest Developments
Table 136. Dechra Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 137. Dechra Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 138. Dechra Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Dechra Main Business
Table 140. Dechra Latest Developments
Table 1. Poultry Live Attenuated Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Poultry Live Attenuated Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of NDV
Table 4. Major Players of Marek ' s Disease
Table 5. Major Players of IBD
Table 6. Major Players of Infectious Bronchitis
Table 7. Major Players of Influenza
Table 8. Major Players of Other
Table 9. Global Poultry Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units)
Table 10. Global Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
Table 11. Global Poultry Live Attenuated Vaccine Revenue by Type (2021-2026) & ($ million)
Table 12. Global Poultry Live Attenuated Vaccine Revenue Market Share by Type (2021-2026)
Table 13. Global Poultry Live Attenuated Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Poultry Live Attenuated Vaccine Sale by Application (2021-2026) & (K Units)
Table 15. Global Poultry Live Attenuated Vaccine Sale Market Share by Application (2021-2026)
Table 16. Global Poultry Live Attenuated Vaccine Revenue by Application (2021-2026) & ($ million)
Table 17. Global Poultry Live Attenuated Vaccine Revenue Market Share by Application (2021-2026)
Table 18. Global Poultry Live Attenuated Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Poultry Live Attenuated Vaccine Sales by Company (2021-2026) & (K Units)
Table 20. Global Poultry Live Attenuated Vaccine Sales Market Share by Company (2021-2026)
Table 21. Global Poultry Live Attenuated Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Poultry Live Attenuated Vaccine Revenue Market Share by Company (2021-2026)
Table 23. Global Poultry Live Attenuated Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Poultry Live Attenuated Vaccine Producing Area Distribution and Sales Area
Table 25. Players Poultry Live Attenuated Vaccine Products Offered
Table 26. Poultry Live Attenuated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Poultry Live Attenuated Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Poultry Live Attenuated Vaccine Sales Market Share Geographic Region (2021-2026)
Table 31. Global Poultry Live Attenuated Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Poultry Live Attenuated Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Poultry Live Attenuated Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Poultry Live Attenuated Vaccine Sales Market Share by Country/Region (2021-2026)
Table 35. Global Poultry Live Attenuated Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Poultry Live Attenuated Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Poultry Live Attenuated Vaccine Sales by Country (2021-2026) & (K Units)
Table 38. Americas Poultry Live Attenuated Vaccine Sales Market Share by Country (2021-2026)
Table 39. Americas Poultry Live Attenuated Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Poultry Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units)
Table 41. Americas Poultry Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units)
Table 42. APAC Poultry Live Attenuated Vaccine Sales by Region (2021-2026) & (K Units)
Table 43. APAC Poultry Live Attenuated Vaccine Sales Market Share by Region (2021-2026)
Table 44. APAC Poultry Live Attenuated Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Poultry Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. APAC Poultry Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Europe Poultry Live Attenuated Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Europe Poultry Live Attenuated Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Poultry Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Europe Poultry Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Poultry Live Attenuated Vaccine Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Poultry Live Attenuated Vaccine Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Poultry Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Poultry Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Poultry Live Attenuated Vaccine
Table 56. Key Market Challenges & Risks of Poultry Live Attenuated Vaccine
Table 57. Key Industry Trends of Poultry Live Attenuated Vaccine
Table 58. Poultry Live Attenuated Vaccine Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Poultry Live Attenuated Vaccine Distributors List
Table 61. Poultry Live Attenuated Vaccine Customer List
Table 62. Global Poultry Live Attenuated Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Poultry Live Attenuated Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Poultry Live Attenuated Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Poultry Live Attenuated Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Poultry Live Attenuated Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Poultry Live Attenuated Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Poultry Live Attenuated Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Poultry Live Attenuated Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Poultry Live Attenuated Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Poultry Live Attenuated Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Poultry Live Attenuated Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Poultry Live Attenuated Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Poultry Live Attenuated Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Poultry Live Attenuated Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. MERCK Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 77. MERCK Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 78. MERCK Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. MERCK Main Business
Table 80. MERCK Latest Developments
Table 81. Boehringer Ingelheim Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 82. Boehringer Ingelheim Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 83. Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Boehringer Ingelheim Main Business
Table 85. Boehringer Ingelheim Latest Developments
Table 86. CEVA Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. CEVA Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 88. CEVA Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. CEVA Main Business
Table 90. CEVA Latest Developments
Table 91. ZOETIS Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. ZOETIS Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 93. ZOETIS Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. ZOETIS Main Business
Table 95. ZOETIS Latest Developments
Table 96. Vaxxinova Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. Vaxxinova Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 98. Vaxxinova Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Vaxxinova Main Business
Table 100. Vaxxinova Latest Developments
Table 101. ELANCO Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. ELANCO Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 103. ELANCO Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. ELANCO Main Business
Table 105. ELANCO Latest Developments
Table 106. QYH BIOTECH Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. QYH BIOTECH Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 108. QYH BIOTECH Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. QYH BIOTECH Main Business
Table 110. QYH BIOTECH Latest Developments
Table 111. PULIKE Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. PULIKE Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 113. PULIKE Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. PULIKE Main Business
Table 115. PULIKE Latest Developments
Table 116. PHIBRO ANIMAL HEALTH CORPORATION Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 117. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 118. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. PHIBRO ANIMAL HEALTH CORPORATION Main Business
Table 120. PHIBRO ANIMAL HEALTH CORPORATION Latest Developments
Table 121. HARBIN PHARMACEUTICAL GROUP Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 123. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. HARBIN PHARMACEUTICAL GROUP Main Business
Table 125. HARBIN PHARMACEUTICAL GROUP Latest Developments
Table 126. MEVAC Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 127. MEVAC Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 128. MEVAC Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. MEVAC Main Business
Table 130. MEVAC Latest Developments
Table 131. VENKY?S Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 132. VENKY?S Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 133. VENKY?S Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. VENKY?S Main Business
Table 135. VENKY?S Latest Developments
Table 136. Dechra Basic Information, Poultry Live Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 137. Dechra Poultry Live Attenuated Vaccine Product Portfolios and Specifications
Table 138. Dechra Poultry Live Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Dechra Main Business
Table 140. Dechra Latest Developments
LIST OF FIGURES
Figure 1. Picture of Poultry Live Attenuated Vaccine
Figure 2. Poultry Live Attenuated Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Poultry Live Attenuated Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Poultry Live Attenuated Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Poultry Live Attenuated Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Poultry Live Attenuated Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Poultry Live Attenuated Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of NDV
Figure 12. Product Picture of Marek ' s Disease
Figure 13. Product Picture of IBD
Figure 14. Product Picture of Infectious Bronchitis
Figure 15. Product Picture of Influenza
Figure 16. Product Picture of Other
Figure 17. Global Poultry Live Attenuated Vaccine Sales Market Share by Type in 2026
Figure 18. Global Poultry Live Attenuated Vaccine Revenue Market Share by Type (2021-2026)
Figure 19. Poultry Live Attenuated Vaccine Consumed in Chicken
Figure 20. Global Poultry Live Attenuated Vaccine Market: Chicken (2021-2026) & (K Units)
Figure 21. Poultry Live Attenuated Vaccine Consumed in Other Poultry
Figure 22. Global Poultry Live Attenuated Vaccine Market: Other Poultry (2021-2026) & (K Units)
Figure 23. Global Poultry Live Attenuated Vaccine Sale Market Share by Application (2025)
Figure 24. Global Poultry Live Attenuated Vaccine Revenue Market Share by Application in 2026
Figure 25. Poultry Live Attenuated Vaccine Sales by Company in 2026 (K Units)
Figure 26. Global Poultry Live Attenuated Vaccine Sales Market Share by Company in 2026
Figure 27. Poultry Live Attenuated Vaccine Revenue by Company in 2026 ($ millions)
Figure 28. Global Poultry Live Attenuated Vaccine Revenue Market Share by Company in 2026
Figure 29. Global Poultry Live Attenuated Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Poultry Live Attenuated Vaccine Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Poultry Live Attenuated Vaccine Sales 2021-2026 (K Units)
Figure 32. Americas Poultry Live Attenuated Vaccine Revenue 2021-2026 ($ millions)
Figure 33. APAC Poultry Live Attenuated Vaccine Sales 2021-2026 (K Units)
Figure 34. APAC Poultry Live Attenuated Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Europe Poultry Live Attenuated Vaccine Sales 2021-2026 (K Units)
Figure 36. Europe Poultry Live Attenuated Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Poultry Live Attenuated Vaccine Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Poultry Live Attenuated Vaccine Revenue 2021-2026 ($ millions)
Figure 39. Americas Poultry Live Attenuated Vaccine Sales Market Share by Country in 2026
Figure 40. Americas Poultry Live Attenuated Vaccine Revenue Market Share by Country (2021-2026)
Figure 41. Americas Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
Figure 42. Americas Poultry Live Attenuated Vaccine Sales Market Share by Application (2021-2026)
Figure 43. United States Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Poultry Live Attenuated Vaccine Sales Market Share by Region in 2026
Figure 48. APAC Poultry Live Attenuated Vaccine Revenue Market Share by Region (2021-2026)
Figure 49. APAC Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
Figure 50. APAC Poultry Live Attenuated Vaccine Sales Market Share by Application (2021-2026)
Figure 51. China Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. India Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Poultry Live Attenuated Vaccine Sales Market Share by Country in 2026
Figure 59. Europe Poultry Live Attenuated Vaccine Revenue Market Share by Country (2021-2026)
Figure 60. Europe Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
Figure 61. Europe Poultry Live Attenuated Vaccine Sales Market Share by Application (2021-2026)
Figure 62. Germany Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. France Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Poultry Live Attenuated Vaccine Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Poultry Live Attenuated Vaccine Sales Market Share by Application (2021-2026)
Figure 70. Egypt Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Poultry Live Attenuated Vaccine in 2026
Figure 76. Manufacturing Process Analysis of Poultry Live Attenuated Vaccine
Figure 77. Industry Chain Structure of Poultry Live Attenuated Vaccine
Figure 78. Channels of Distribution
Figure 79. Global Poultry Live Attenuated Vaccine Sales Market Forecast by Region (2027-2032)
Figure 80. Global Poultry Live Attenuated Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Poultry Live Attenuated Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Poultry Live Attenuated Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Poultry Live Attenuated Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Poultry Live Attenuated Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Poultry Live Attenuated Vaccine
Figure 2. Poultry Live Attenuated Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Poultry Live Attenuated Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Poultry Live Attenuated Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Poultry Live Attenuated Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Poultry Live Attenuated Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Poultry Live Attenuated Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of NDV
Figure 12. Product Picture of Marek ' s Disease
Figure 13. Product Picture of IBD
Figure 14. Product Picture of Infectious Bronchitis
Figure 15. Product Picture of Influenza
Figure 16. Product Picture of Other
Figure 17. Global Poultry Live Attenuated Vaccine Sales Market Share by Type in 2026
Figure 18. Global Poultry Live Attenuated Vaccine Revenue Market Share by Type (2021-2026)
Figure 19. Poultry Live Attenuated Vaccine Consumed in Chicken
Figure 20. Global Poultry Live Attenuated Vaccine Market: Chicken (2021-2026) & (K Units)
Figure 21. Poultry Live Attenuated Vaccine Consumed in Other Poultry
Figure 22. Global Poultry Live Attenuated Vaccine Market: Other Poultry (2021-2026) & (K Units)
Figure 23. Global Poultry Live Attenuated Vaccine Sale Market Share by Application (2025)
Figure 24. Global Poultry Live Attenuated Vaccine Revenue Market Share by Application in 2026
Figure 25. Poultry Live Attenuated Vaccine Sales by Company in 2026 (K Units)
Figure 26. Global Poultry Live Attenuated Vaccine Sales Market Share by Company in 2026
Figure 27. Poultry Live Attenuated Vaccine Revenue by Company in 2026 ($ millions)
Figure 28. Global Poultry Live Attenuated Vaccine Revenue Market Share by Company in 2026
Figure 29. Global Poultry Live Attenuated Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Poultry Live Attenuated Vaccine Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Poultry Live Attenuated Vaccine Sales 2021-2026 (K Units)
Figure 32. Americas Poultry Live Attenuated Vaccine Revenue 2021-2026 ($ millions)
Figure 33. APAC Poultry Live Attenuated Vaccine Sales 2021-2026 (K Units)
Figure 34. APAC Poultry Live Attenuated Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Europe Poultry Live Attenuated Vaccine Sales 2021-2026 (K Units)
Figure 36. Europe Poultry Live Attenuated Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Poultry Live Attenuated Vaccine Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Poultry Live Attenuated Vaccine Revenue 2021-2026 ($ millions)
Figure 39. Americas Poultry Live Attenuated Vaccine Sales Market Share by Country in 2026
Figure 40. Americas Poultry Live Attenuated Vaccine Revenue Market Share by Country (2021-2026)
Figure 41. Americas Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
Figure 42. Americas Poultry Live Attenuated Vaccine Sales Market Share by Application (2021-2026)
Figure 43. United States Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Poultry Live Attenuated Vaccine Sales Market Share by Region in 2026
Figure 48. APAC Poultry Live Attenuated Vaccine Revenue Market Share by Region (2021-2026)
Figure 49. APAC Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
Figure 50. APAC Poultry Live Attenuated Vaccine Sales Market Share by Application (2021-2026)
Figure 51. China Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. India Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Poultry Live Attenuated Vaccine Sales Market Share by Country in 2026
Figure 59. Europe Poultry Live Attenuated Vaccine Revenue Market Share by Country (2021-2026)
Figure 60. Europe Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
Figure 61. Europe Poultry Live Attenuated Vaccine Sales Market Share by Application (2021-2026)
Figure 62. Germany Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. France Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Poultry Live Attenuated Vaccine Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Poultry Live Attenuated Vaccine Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Poultry Live Attenuated Vaccine Sales Market Share by Application (2021-2026)
Figure 70. Egypt Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Poultry Live Attenuated Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Poultry Live Attenuated Vaccine in 2026
Figure 76. Manufacturing Process Analysis of Poultry Live Attenuated Vaccine
Figure 77. Industry Chain Structure of Poultry Live Attenuated Vaccine
Figure 78. Channels of Distribution
Figure 79. Global Poultry Live Attenuated Vaccine Sales Market Forecast by Region (2027-2032)
Figure 80. Global Poultry Live Attenuated Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Poultry Live Attenuated Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Poultry Live Attenuated Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Poultry Live Attenuated Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Poultry Live Attenuated Vaccine Revenue Market Share Forecast by Application (2027-2032)
